NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter DemuthChief Scientific Officer2025-12-09362$4.41
$1.60kBuy
Yekaterina ChudnovskyDirector2025-03-053,500,573$5.81
$20.34MBuy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky30.97%5,416,212$45.77MInsider
Eisaabc LLC15.67%2,740,978$23.16MInsider
Itzhak Goldberg9.65%1,687,986$14.26MInsider
Victor F. Ganzi5.60%978,698$8.27MInsider
Knoll Capital Management LLC3.61%630,915$5.33MInstitution
Vanguard Group Inc2.71%473,859$4.00MInstitution
Jay Venkatesan1.03%180,534$1.53MInsider
Balyasny Asset Management LP0.85%148,076$1.25MInstitution
Geode Capital Management LLC0.74%129,686$1.10MInstitution
Susquehanna International Group LLP0.69%120,207$1.02MInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX10.93%64.39%Net BuyingNet Buying
VOR22.63%77.37%Net SellingNet Selling
CRBU39.75%8.81%Net Buying
THAR2.30%15.90%Net Buying
BDTX65.77%34.23%Net SellingNet Buying

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 10.93% institutional shareholders, 64.39% Elicio Therapeutics insiders, and 24.68% retail investors. Yekaterina Chudnovsky is the largest individual Elicio Therapeutics shareholder, owning 5.42M shares representing 30.97% of the company. Yekaterina Chudnovsky's Elicio Therapeutics shares are currently valued at $44.36M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.